Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Omega Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 58 | 58 | 0 |
| Shares | 51.1M | 50.9M | −203.9K (−0.4%) |
| Value | $286.1M | $109.4M | −$176.7M (−61.8%) |
New holders (6)
Institutions that held Omega Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 68,765 | $147.8K | 0.00% |
| American Century Companies Inc | 12,225 | $26.3K | 0.00% |
| Group One Trading, L.P. | 2,663 | $5.72K | 0.00% |
| Allspring Global Investments Holdings, LLC | 2,577 | $5.54K | 0.00% |
| Sandy Spring Bank | 250 | $538 | 0.00% |
| Nisa Investment Advisors, LLC | 31 | $67 | 0.00% |
Sold out (6)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Laurion Capital Management LP | 24,155 | $135.3K |
| MetLife Investment Management | 13,737 | $76.9K |
| Manufacturers Life Insurance Company, The | 11,027 | $61.8K |
| Metropolitan Life Insurance Co | 1,423 | $7.97K |
| Parallel Advisors, LLC | 296 | $1.66K |
| State of Wyoming | 167 | $935 |